Ard, Jamy D.
Wake Forest University Health Sciences · Wake Forest University
23 papers on CoChatORCID 0000-0002-1643-6795
Most cited papers
- Verified
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology
Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 4,058
- Verified
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation
Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 2,735
- Verified · note
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation
Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention
Cited by 2,261
- Verified
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology
Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention
Cited by 1,160
- Verified
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., Mao, H., Zhang, S., Ahmad, N. N., Bunck, M. C., et al. (2023) · The Lancet
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 792
- Verified
Meal timing and frequency: implications for cardiovascular disease prevention: A scientific statement from the american heart association
St-Onge, M.-P., Ard, J., Baskin, M. L., Chiuve, S. E., Johnson, H. M., Kris-Etherton, P., & Varady, K. (2017) · Circulation
Dietary Effects on HealthNutritional Studies and Diet
Cited by 728
- Verified
Effects of Comprehensive Lifestyle Modification on Diet, Weight, Physical Fitness, and Blood Pressure Control: 18-Month Results of a Randomized Trial
Elmer, P. J., Obarzanek, E., Vollmer, W. M., Simons-Morton, D., Stevens, V. J., Young, D. R., Lin, P.-H., Champagne, C., Harsha, D. W., Svetkey, L. P., et al. (2006) · Annals of Internal Medicine
Blood Pressure and Hypertension StudiesSodium Intake and Health
Cited by 596
- Verified
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Wadden, T. A., Chao, A. M., Machineni, S., Kushner, R., Ard, J., Srivastava, G., Halpern, B., Zhang, S., Chen, J., Bunck, M. C., et al. (2023) · Nature Medicine
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 442
- Verified
Weight loss during the intensive intervention phase of the weight-loss maintenance trial
Hollis, J. F., Gullion, C. M., Stevens, V. J., Brantley, P. J., Appel, L. J., Ard, J. D., Champagne, C. M., Dalcin, A., Erlinger, T. P., Funk, K., et al. (2008) · American Journal of Preventive Medicine
Obesity, Physical Activity, DietPharmacology and Obesity Treatment
Cited by 321
- Verified
Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists
Ard, J., Fitch, A., Fruh, S., & Herman, L. (2021) · Advances in Therapy
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 297
- Verified
Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial
Chen, L., Appel, L. J., Loria, C., Lin, P.-H., Champagne, C. M., Elmer, P. J., Ard, J. D., Mitchell, D., Batch, B. C., Svetkey, L. P., et al. (2009) · The American Journal of Clinical Nutrition
Obesity, Physical Activity, DietDiet, Metabolism, and Disease
Cited by 250
- Verified
Reductions in dietary energy density are associated with weight loss in overweight and obese participants in the PREMIER trial
Ledikwe, J. H., Rolls, B. J., Smiciklas-Wright, H., Mitchell, D. C., Ard, J. D., Champagne, C., Karanja, N., Lin, P.-H., Stevens, V. J., & Appel, L. J. (2007) · The American Journal of Clinical Nutrition
Nutritional Studies and DietNutrition, Health and Food Behavior
Cited by 204
- Verified
Evaluation of Dietary Patterns and All-Cause Mortality: A Systematic Review
English, L. K., Ard, J. D., Bailey, R. L., Bates, M., Bazzano, L. A., Boushey, C. J., Brown, C., Butera, G., Callahan, E. H., de Jesus, J., et al. (2021) · JAMA Network Open
Nutritional Studies and DietNutrition, Health, and Society Studies
Cited by 203
- Verified
Twenty-First Century Behavioral Medicine: A Context for Empowering Clinicians and Patients With Diabetes
Marrero, D. G., Ard, J., Delamater, A. M., Peragallo-Dittko, V., Mayer-Davis, E. J., Nwankwo, R., & Fisher, E. B. (2013) · Diabetes Care
Diabetes Management and EducationBehavioral Health and Interventions
Cited by 159
- Verified
Nutritional considerations with antiobesity medications
Almandoz, J. P., Wadden, T. A., Tewksbury, C., Apovian, C. M., Fitch, A., Ard, J. D., Li, Z., Richards, J., Butsch, W. S., Jouravskaya, I., et al. (2024) · Obesity
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 134
- Verified
Safety and Effectiveness of Longer‐Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort
Lewis, K. H., Fischer, H., Ard, J., Barton, L., Bessesen, D. H., Daley, M. F., Desai, J., Fitzpatrick, S. L., Horberg, M., Koebnick, C., et al. (2019) · Obesity
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 110
- Verified
The Effect of the PREMIER Interventions on Insulin Sensitivity
Ard, J. D., Grambow, S. C., Liu, D., Slentz, C. A., Kraus, W. E., & Svetkey, L. P. (2004) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsBlood Pressure and Hypertension Studies
Cited by 106
- Verified
Effectiveness of a Total Meal Replacement Program (OPTIFAST Program) on Weight Loss: Results from the OPTIWIN Study
Ard, J. D., Lewis, K. H., Rothberg, A., Auriemma, A., Coburn, S. L., Cohen, S. S., Loper, J., Matarese, L., Pories, W. J., & Periman, S. (2019) · Obesity
Diet and metabolism studiesPharmacology and Obesity Treatment
Cited by 106
- Verified
Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials
Ard, J., Cannon, A., Lewis, C. E., Lofton, H., Vang Skjøth, T., Stevenin, B., & Pi‐Sunyer, X. (2016) · Diabetes, Obesity and Metabolism
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 43
- Verified
G LP1Ra ‐based therapies and DXA ‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials
Beavers, K. M., Cortes, T. M., Foy, C. M., Dinkla, L., Reyes San Martin, F., Ard, J. D., Serra, M. C., & Beavers, D. P. (2025) · Obesity
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 41
- Verified
Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
Ard, J. D., Hong, Y., Foster, G. D., Medcalf, A., Nadolsky, S., & Cardel, M. I. (2024) · Obesity
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 18
- Verified
The latest evidence and clinical guidelines for use of meal replacements in very-low-calorie diets or low-calorie diets for the treatment of obesity
Edwards‐Hampton, S. A., & Ard, J. (2024) · Diabetes, Obesity and Metabolism
Diet and metabolism studiesDietary Effects on Health
Cited by 17
- Verified
The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study
Ard, J. D., Neeland, I. J., Rothberg, A. E., Chilton, R. J., de Luis, D., Cohen, S. S., & Johansen, O. E. (2024) · Diabetes, Obesity and Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and Outcomes
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free